rs374107286
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001277115.2(DNAH11):c.3544C>T(p.Arg1182*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001277115.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248738Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134930
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461414Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 726976
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151998Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74236
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 01, 2023 | This sequence change creates a premature translational stop signal (p.Arg1182*) in the DNAH11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH11 are known to be pathogenic (PMID: 18022865, 20513915, 22184204). This variant is present in population databases (rs374107286, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 29467202). ClinVar contains an entry for this variant (Variation ID: 577162). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2018 | The p.R1182* pathogenic mutation (also known as c.3544C>T), located in coding exon 18 of the DNAH11 gene, results from a C to T substitution at nucleotide position 3544. This changes the amino acid from an arginine to a stop codon within coding exon 18. This mutation was identified in an individual with primary ciliary dyskinesia in conjunction with a second DNAH11 alteration (Shoemark A et al. Eur. Respir. J., 2018 Feb;51(2)). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
DNAH11-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 21, 2023 | The DNAH11 c.3544C>T variant is predicted to result in premature protein termination (p.Arg1182*). This variant has been reported along with a second DNAH11 variant in an individual with primary ciliary dyskinesia (Shoemark et al 2018. PubMed ID: 29467202). This variant is reported in 0.0056% of alleles in individuals of East Asian descent in gnomAD. Nonsense variants in DNAH11 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Primary ciliary dyskinesia 7 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 25, 2022 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2024 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 38319496, 33715250, 29467202) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at